Fact CheckerSign in

NCT04770207RecruitingPhase 2

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Intra-tumor Injection of Drug-eluting Microspheres Loading With Chemodrug Plus Checkpoint Inhibitors and/or IL2 for Treatment of Advanced Solid Tumors

Source: ClinicalTrials.gov · Last updated 21 Aug 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
First submitted
2 Dec 2020
Start date
1 Nov 2020
Primary completion date
1 Nov 2029
Lead sponsor
Second Affiliated Hospital of Guangzhou Medical University
NCT number
NCT04770207

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 100
  • From 1 Nov 2020 to the primary completion date, 1 Nov 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Benign tumor
  • Life expectancy is less than three months
  • Serious medical comorbidity
  • Others

Who the study is looking for

  • Solid advanced malignant tumors
  • Age between18 and 99 years
  • Life expectancy is greater than three months

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The second Affiliated Hospital of Guangzhou Medical University
Coordinator of this site? Confirm its status		GuangzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.